50 related articles for article (PubMed ID: 27278746)
1. Classification of ultrasonographic images of small hepatocellular carcinoma using galactose-based contrast agent: relation between image patterns and histologic features.
Matsuda Y; Yabuuchi I; Ito T; Arima R
J Med Ultrason (2001); 2004 Sep; 31(3):111-20. PubMed ID: 27278746
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
3. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
5. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.
Jang HJ; Kim TK; Burns PN; Wilson SR
Radiology; 2007 Sep; 244(3):898-906. PubMed ID: 17709836
[TBL] [Abstract][Full Text] [Related]
6. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma.
Muhi A; Ichikawa T; Motosugi U; Sano K; Matsuda M; Kitamura T; Nakazawa T; Araki T
J Magn Reson Imaging; 2009 Nov; 30(5):1005-11. PubMed ID: 19856432
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
[TBL] [Abstract][Full Text] [Related]
8. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: US evolution in the early stage.
Sheu JC; Chen DS; Sung JL; Chuang CN; Yang PM; Lin JT; Yang PC
Radiology; 1985 May; 155(2):463-7. PubMed ID: 2984721
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics.
Choi JY; Kim MJ; Park YN; Lee JM; Yoo SK; Rha SY; Seok JY
AJR Am J Roentgenol; 2011 Aug; 197(2):399-405. PubMed ID: 21785086
[TBL] [Abstract][Full Text] [Related]
12. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.
Park VY; Choi JY; Chung YE; Kim H; Park MS; Lim JS; Kim KW; Kim MJ
Liver Int; 2014 Nov; 34(10):1593-602. PubMed ID: 24673802
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
Goshima S; Kanematsu M; Watanabe H; Kondo H; Mizuno N; Kawada H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
[TBL] [Abstract][Full Text] [Related]
14. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
15. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
Ishigami K; Yoshimitsu K; Nishihara Y; Irie H; Asayama Y; Tajima T; Nishie A; Hirakawa M; Ushijima Y; Okamoto D; Taketomi A; Honda H
Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K
Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?
Shirabe K; Matsumata T; Adachi E; Maeda T; Shimada M; Taketomi A; Sugimachi K
Hepatogastroenterology; 1995; 42(6):923-30. PubMed ID: 8847047
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
20. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]